Insider Selling: Globe Life (NYSE:GL) CEO Sells 12,500 Shares of Stock

Globe Life Inc. (NYSE:GL) CEO Frank Svoboda sold 12,500 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $144.78, for a total value of $1,809,750.00. Following the sale, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at $5,192,969.04. This represents a 25.84% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Globe Life Stock Performance

NYSE GL traded down $2.13 on Wednesday, reaching $143.79. 411,628 shares of the stock were exchanged, compared to its average volume of 522,295. Globe Life Inc. has a one year low of $109.38 and a one year high of $152.71. The firm has a market capitalization of $11.45 billion, a PE ratio of 10.21 and a beta of 0.47. The company’s 50-day simple moving average is $141.06 and its two-hundred day simple moving average is $138.48. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.41.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The firm had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter in the previous year, the business earned $3.14 earnings per share. The firm’s revenue for the quarter was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Analysts expect that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Institutional Investors Weigh In On Globe Life

Several large investors have recently modified their holdings of GL. Mather Group LLC. purchased a new stake in Globe Life during the third quarter worth $28,000. CYBER HORNET ETFs LLC bought a new position in shares of Globe Life in the 2nd quarter worth $28,000. Assetmark Inc. raised its position in shares of Globe Life by 777.8% in the 2nd quarter. Assetmark Inc. now owns 237 shares of the company’s stock worth $29,000 after acquiring an additional 210 shares in the last quarter. Hilton Head Capital Partners LLC purchased a new stake in shares of Globe Life during the 4th quarter worth $30,000. Finally, MUFG Securities EMEA plc bought a new stake in Globe Life during the second quarter valued at about $31,000. Institutional investors own 81.61% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on GL. Weiss Ratings upgraded shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, February 13th. Piper Sandler reissued an “overweight” rating and set a $167.00 price target on shares of Globe Life in a research note on Friday, November 21st. Morgan Stanley reaffirmed an “overweight” rating and issued a $176.00 price objective on shares of Globe Life in a research note on Monday, December 15th. TD Cowen reiterated a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Finally, Evercore set a $157.00 price target on shares of Globe Life in a research report on Wednesday. Eight research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, Globe Life has an average rating of “Moderate Buy” and an average target price of $171.22.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.